Este comunicado de imprensa inclui multimédia. Veja o comunicado completo aqui: Textron Aviation expands high speed cabin ...
Textron Aviation Inc., ein Unternehmen der Textron Inc. (NYSE: TXT), gab heute die Verfügbarkeit von Gogo 5G bekannt, einem ...
Textron Aviation expands high speed cabin connectivity with Gogo 5G upgrade for Cessna Citation business jets “Reliable, high ...
ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...
(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...
Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...
The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...
NEW YORK and MIAMI, Oct. 7, 2025 /PRNewswire/ -- Avance Investment Management ("Avance") today announced a strategic partnership with Barchemy, LLC ("Barchemy"), a leading developer and manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results